NovoCure Earnings Preview
Portfolio Pulse from Benzinga Insights
NovoCure (NASDAQ:NVCR) is set to release its quarterly earnings report on July 27, 2023. Analysts estimate an earnings per share (EPS) of -$0.50. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. The company's shares are currently trading at $38.97, down 42.65% over the last 52-week period.
July 26, 2023 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NovoCure's upcoming earnings report could impact its stock price. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varied stock price changes. The company's shares are currently down 42.65% over the last 52-week period.
NovoCure's stock price has shown to be sensitive to its earnings reports. Given the company's mixed history of beating and missing EPS estimates, the upcoming earnings report could potentially impact its stock price. However, it's also important to note that the company's shares have been on a downward trend over the last 52-week period, which could influence investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100